In patients with type 2 diabetes, the local inflammation of periodontitis leads to enhanced systemic inflammation, decreased adiponectin levels, and lipid metabolism disorders, creating an imbalance between pro-inflammatory and anti-inflammatory effects (39). The gene discussed is ADIPOQ; the disease is periodontitis.